The choice of therapy depends on multiple factors, including medical history, side effect profile, convenience, cost, and personal preferences
Conrad N, Judge A, Tran J, et al
Never get complacent continue your quest to heal your shoulder without surgery because a solution may be right around the corner
Current Availability and Regulatory Status in the UK Retatrutide is not approved for clinical use in the UK as of April 2025 and can only be accessed through MHRA-registered clinical trials
We do not have dose-response data to say whether sub-maximal doses of GLP-1 RAs (for example, in patients who do not want or cannot tolerate the full dose) are effective
This is non-negotiable based on current evidence